You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: May 5, 2024

CLINICAL TRIALS PROFILE FOR SABARUBICIN

✉ Email this page to a colleague

« Back to Dashboard

Clinical Trials for Sabarubicin

Subscribe to access the full database, or Try a Trial
Trial ID	Title	Status	Sponsor	Phase	Summary
NCT00003028 ↗	MEN-10755 in Treating Adults With Recurrent or Refractory Solid Tumors	Completed	European Organisation for Research and Treatment of Cancer - EORTC	Phase 1	RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase I trial to study the effectiveness of MEN-10755 in treating adults who have recurrent or refractory solid tumors.
NCT00003982 ↗	MEN-10755 in Treating Patients With Solid Tumors	Completed	European Organisation for Research and Treatment of Cancer - EORTC	Phase 1	RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase I trial to study the effectiveness of MEN-10755 in treating patients who have solid tumors.
NCT00027781 ↗	MEN-10755 in Treating Patients With Progressive Prostate Cancer That Has Not Responded to Hormone Therapy	Completed	European Organisation for Research and Treatment of Cancer - EORTC	Phase 2	RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of MEN-10755 in treating patients who have progressive prostate cancer that has not responded to hormone therapy.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Summary

Clinical Trial Conditions for Sabarubicin

Condition Name

Chart
Table

Condition Name for
Intervention	Trials
Unspecified Adult Solid Tumor, Protocol Specific	2
Prostate Cancer	1
Testicular Germ Cell Tumor	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for
Intervention	Trials
Neoplasms	2
Prostatic Neoplasms	1
Testicular Neoplasms	1
Neoplasms, Germ Cell and Embryonal	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for Sabarubicin

Trials by Country

Map
Table

Trials by Country for
Location	Trials
United Kingdom	4
Switzerland	3
Belgium	3
Germany	3
France	3
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for Sabarubicin

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for
Clinical Trial Phase	Trials
Phase 2	1
Phase 1	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for
Clinical Trial Phase	Trials
Completed	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Sabarubicin

Sponsor Name

Chart
Table

Sponsor Name for
Sponsor	Trials
European Organisation for Research and Treatment of Cancer - EORTC	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for
Sponsor	Trials
Other	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.